Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Cryo-Cell International, Inc. (CCEL)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
6.65+0.06 (+0.97%)
At close: 03:01PM EDT
6.51 -0.14 (-2.11%)
After hours: 04:35PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close6.59
Open6.79
Bid6.06 x 1400
Ask7.02 x 900
Day's Range6.51 - 7.00
52 Week Range5.00 - 14.00
Volume2,892
Avg. Volume6,222
Market Cap56.727M
Beta (5Y Monthly)0.58
PE Ratio (TTM)14.78
EPS (TTM)0.45
Earnings DateFeb 22, 2022 - Feb 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Cord Blood Banking Leader Cryo-Cell Announces Special Cash Dividend

    OLDSMAR, Fla., Aug. 22, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (“Cryo-Cell”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced today that its Board of Directors declares a one-time, special cash dividend of $0.90 per share of common stock to be paid to its shareholders of record as of the close of business on September 2, 2022. Cryo-Cell’s Chairman of the Board and Co-CEO, David Portnoy, stated “C

  • GlobeNewswire

    Cord Blood Banking Leader Cryo-Cell Announces Transfer to the NYSE American Stock Exchange

    OLDSMAR, Fla., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (“Cryo-Cell”, the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced today that it will change its listing from the Nasdaq Capital Market to the NYSE American stock exchange on August 30, 2022. David Portnoy, Chairman and Co-CEO of Cryo-Cell, said, “The New York Stock Exchange has been trading stocks for over 225 years and is

  • GlobeNewswire

    Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2022 Financial Results

    OLDSMAR, Fla., July 11, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second quarter ended May 31, 2022. Financial Results Revenue Consolidated revenues for the second quarter of fiscal 2022 were $7.63 million compared to $7.21 million for the second quarter of fiscal 2021, a 6% increase. The revenues for the second

Advertisement
Advertisement